Demand pull is outrunning the plan for one still-small offering, and the company is visibly re-pointing itself at it
The model's full reasoning — Q2 2023 call → NOWe need to determine if management describes an offering with both: (1) customer response running ahead of what company prepared for, and (2) company responding now by putting more behind it. Also offering is still small relative to total business. Scan transcript for such descriptions. Look for mentions of products/services with strong uptake and expansion. Possible candidates: Apple savings account? Credit card partnerships? Transaction banking? Asset management? Equities financing? But need specific. Search for phrases like "ahead of", "exceeded", "stronger than expected", "demand", "capacity", "rollout", "adoption", "outpacing". In transcript, David Solomon mentions: "We launched an Apple savings platform which also was a successful launch to grow our deposit base." That's about deposits. But no mention of demand exceeding preparation. Also mentions "transaction banking" as a business that is small and they are working on getting clients to use more. But no mention of demand ahead of plan. Check for "GreenSky" - they are exploring sale, not expansion. Check for "financing" - they are growing but that's main business. Check for "asset management" - they have inflows but not described as ahead of plan. Look for any specific offering where management says uptake is stronger than expected and they are scaling up. For example, maybe "Marcus" loans? But they sold that. Search for "exceed" or "ahead" in transcript. I see "we have now largely reached this organ with line of sight to surpass it" about efficiency ratio. Not about customer demand. Also "we are well on pace to achieve our 2024 target" for fundraising. No clear instance of customer response running ahead of preparation. Thus answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
HCKT · Q1 2024 → YESThe question is about whether management describes one identifiable offering that's still small, where customer response is ahead of what they prepared for, AND they're responding now by putting more ...YES The transcript describes AI Explorer (the GenAI assessment platform) as a small, early-stage offering (nominal Q1 revenue impact, part of broader GenAI pivot). Management states customer response is exceeding preparation: "over 175 demo meetings with many more scheduled... resulted in a number of new enterprise...
SYY · Q1 2023 → YESThe question is about whether management describes one identifiable offering or initiative that's still a smaller part of the business, where customer response is running ahead of what they prepared f...YES The transcript shows that Sysco Your Way is presented as a smaller, still-developing offering (described as part of the Recipe For Growth pillars, with its scale expected to grow each quarter and currently limited to specific neighborhoods and recent international rollouts like Toronto and Dublin).
PRPH · Q1 2023 → YESThe question asks if management describes one identifiable offering that's still a smaller part of the business, where customer response is running ahead of what they prepared for, AND they're respond...YES The lozenge manufacturing facility is the clearest match. It is explicitly described as “the least interesting business we’re developing” and still a smaller slice of overall results (COVID testing was the dominant revenue driver for the prior two years).